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The protein II (PII) outer membrane proteins of Neisseria gonorrhoeae are a family of heat-modifiable
proteins that are subject to phase variation, in which the synthesis of different PI' species is turned on and off
at a high frequency. Transformation of PH genes from a donor gonococcal strain into a recipient strain was
detected with monoclonal antibodies specific for the PII proteins of the donor. Individual PIT protein-expressing
transformants generally bound only one donor-specific PIT monoclonal antibody. Recovery of transformants
expressing a donor-specific PII protein depended on the PH protein expression state of the donor: the
transformed population bound only monoclonai antibodies specific for PH proteims that were expressed in the
donor. Colony' variants with an altered frequency of switching of PII protein expression were isolated, but the
altered switch phenotype did not cotransform with the PIT structural gene. These results provide genetic
evidence that PH proteins are the products of different gepes and that expressed and unexpressed forms of the
PIH gene are different from each other.
Neisseria gonorrhoeae is capable of rapid, reversible
changes in the expression of virulence-associated proteins
(5). This variation can aid in the evasion of host immune
responses and may in part be responsible for recurrent
gonococcal infections (13, 31). Our interest has centered on
one group of variable proteins, designated protein(s) II (PII).
The PII proteins of the gonococcus are a family 'of
heat-modifiable outer membrane proteins with apparent mo-
lecular masses ranging from 24,000'to 30,000 daltons (28).
They were initially described as proteins present in the outer
membrane of dark-colored (opaque) colony variants and
absent in light (transparent) variants of the same strain (28,
30). The gonococcus reversibly oscillates between on and off
states of expression of PII proteins in a type of phase
variation (11, 29). The proteins are apparently not crucial to
viability, since in all strains studied there are colony variants
that do not express PII proteins.'PII proteins also demon-
strate antigenic variation, whereby the synthesis of antigen-
ically different PII proteins of a strain is turned on and off. At
least seven distinct'PII species have been described in one
gonococcal strain, and an organism can express from zero to
at least three PII proteins at one time (22). Gonococci
expressing PII proteins are generally isolated from infections
localized to the surface mucosa, whereas organisms recov-
ered from disseminated infections often lack PII proteins (6,
7). The possession of certain PII proteins has been associ-
ated with resistance to antibiotics and steroid hormones (12,
19), altered-serum resistance (8, 12), increased sensitivity to
serum proteases (2), and increased adherence to buccal
epithelial cells (12) and phagocytic cells (18).
Little is known about the genes for PII proteins or about
the mechanisms that regulate PII protein expression. Within
a gonococcal population, variants that differ in PII protein
profiles (detected by differences in colony opacity) occur at
a frequency of approximately 10-3 per cell per generation
(16). Switching of 'PII proteins occurs in a nonrandom
sequence (1, 29). Studies with cloned genes for PII proteins
showed that there are multiple' copies of PII-related se-
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quences in the gonococcal chromosome and that structural
alterations in DNA accomnpany changes in PIT protein ex-
pression (26, 27).
Studies on the physical characterization of PIT genes
would be complemented by studies on the genetics of PII
proteins in the gonococcus itself. However, since the pres-
ence of PII proteins does not confer a selectable phenotype
on the gonococcus, it has been difficult to apply traditional
genetic approaches to the study of PII genes. We have done
experiments involving the genetic transformation of PII
genes in which transformants expressing a donor-specific PII
protein were detected with monoclonal antibodies (MAb)
specific for the PII proteins of the donor. This approach has
allowed us to investigate the linkage relationships of genes
for PII proteins and to determine that the state of expression
of a donor PH gene affects the outcome of genetic transfor-
mation experiments. We also report that variants of a single
strain can differ in the frequency of switching of a particular
PIT protein.
MATERIALS AND METHODS
Strains and growth conditions. N. gonorrhoeae FA1090 is
a serum-resistant, prototrophic strain isolated from a patient
with a probable disseminated gonococcal infection (17).
Strains FA19 (20) and FA759 were from the strain collection
of P. F. Sparling. Gonococci were grown on GCB agar
(Difco Laboratories) with the supplements of Kellogg et al.
(9). They were incubated at 37°C in a 4% CO2 atmosphere.
The derivation of FA1090 colony variants, each expressing
an electrophoretically distinct PII protein, has been
previously discussed (1). In some cases, a colony blot
radioimmunoassay (RIA) (see below) with different P1l
protein-specific MAb was used to identify colony variants
expressing more than one P1l protein. Single colonies were
picked and passed onto fresh agar plates each day. Colonies
were chosen on' the basis of opacity characteristics (which
correlate partially with specific PII protein expression) by
the criteria of Swanson (28). The PII protein excpression of
variants used in these experiments was always verified by
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FIG. 1. P.11 proteins of N. gonorrhoeae FA1090. Lithium ace-
tate-extracted outer membranes were solubilized at 37°C for 60 min
and electrophoresed on a 4 to 30% polyacrylamide gradient gel.
Lanes: S, Electrophoretic molecular weight standards (Bio-Rad
Laboratories); -, P.II protein-negative variants; a through f, vari-
ants expressing P.IIa through P.IIf, respectively. K, Thousand.
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE).
Outer membrane isolation. Bacteria were scraped from an
agar plate, and outer membranes were isolated by lithium
acetate extraction as previously described (1).
SDS-PAGE. Outer membrane suspension (20 ,ul; approxi-
mately 25 p.g of protein) was added to 20 of solubilizing
solution and incubated at 37°C for 60 min or at 100°C for 5
min. Samples were subjected to electrophoresis on 4 to 30%
linear polyacrylamide gradient gels by using the buffer
system of Laemmli (10). Gels were stained with Coomassie
brilliant blue.
Western transfer. Procedures for Western transfer to
nitrocellulose (Schleicher & Schuell, Inc.) and probing with
MAb and 125I-protein A (Amersham Corp.) have been de-
scribed previously (1, 3).
Colony blot filter RIA. Gonococcal colonies were assayed
for the binding of MAb by a colony blot RIA as previously
described (1). Colonies were blotted from agar plates with
sterile Whatman no. 42 filter paper disks. Filters were
probed sequentially with antibody and 125I-protein A and
autoradiographed.
Genetic transformation. Transforming DNA was prepared
as described by Cannon and Bott (4) or Marmur (15) from
organisms grown in GCB broth (Difco) with the supplements
of Kellogg et al. (9). Transforming DNA prepared from
organisms of known PII protein composition was incubated
under nonsaturating conditions with competent (piliated)
cells for 30 min at 37°C Gonococci were plated on GCB agar
and incubated at 37°C for 40 h. Transformants expressing
FA1090 PII proteins were identified by a colony blot RIA
with FA1090 Pll protein-specific MAb. Single colonies pro-
ducing a positive autoradiography signal were cloned for
further study. Controls included DNase-treated DNA and
nontransformed recipient cells. Antibiotic-resistant trans-
formants were isolated by procedures described previously
(20). FA1090 is streptomycin resistant. Spontaneous rif-
ampin- and spectinomycin-resistant mutants of FA1090 were
selected on agar plates containing 2 ,ug of rifampin or 200 ,ug
of spectinomycin per ml.
Bactericidal assay. A complement-dependent bactericidal
assay was performed as previously described (1) with minor
modifications. Individual gonococcal colonies were added to
200 ,ul of GCB broth. A 50-,ul quantity of this suspension was
added to a microtiter well containing 25 ,ul of pooled normal
human serum and 25 ,ul of hybridoma culture supernatant
that had been dialyzed against phosphate-buffered saline
(PBS) to remove antibiotics. Viability was calculated as
[(CFU after exposure to antibody and complement)/(CFU in
controls without antibody and complement)] x 100.
RESULTS AND DISCUSSION
Transformation of genes for PII proteins. Gonococci are
highly competent for genetic transformation (25), and we
wished to use transformation as a means to study the linkage
of genes for PII proteins. For detection of the introduction of
a donor gene into the chromosome of a recipient, it is
necessary to have a means to select for appropriate trans-
formants or to distinguish the gene products of the donor and
recipient. We have previously described MAb specific for
the P.II proteins of gonococcal strain FA1090. This strain is
capable of expressing at least six electrophoretically distinct
P.JI species, designated P.IIa through P.IIf, in order of
increasing apparent molecular weight (1) (Fig. 1). Antibody
H.4a binds to P.IIb and P.IId, and antibody H.138.2 binds to
P.IIa only (1). In addition, we have produced antibodies that
bind specifically to P.IIc, P.IIe, and P.IIf (D. Barritt and J.
Cannon, unpublished data). To determine if the MAb could
be used to detect the transformation of P.II genes, we
prepared transforming DNA from strain FA1090 colony
variants that expressed a specific P.II protein, as determined
by SDS-PAGE and MAb binding. The recipient strains were
FA19 and FA759, which did not bind the MAb specific for
FA1090 proteins, as assayed by a colony blot RIA or
Western blotting. The recipient strains were fully capable of
expressing P.11 proteins, but none of those proteins bound
the FA1090 P.11 protein-specific MAb. After incubation of
donor DNA and recipient cells, the mixture was plated.
Antibody-binding transformants were identified by a colony
blot RIA with the MAb as probes. Colonies that bound
antibody were cloned, and the presence of the donor-type
P.II protein was confirmed by Western blotting (Fig. 2).
When either strain FA19 or FA759 was used as the recipient,
transformants identified as antibody binding in the colony
blot RIA produced an antibody-binding P.11 protein with the
same apparent molecular weight as that of the donor-type
P.11 protein. Thus, screening transformation mixtures with
MAb provided a successful means of recovering transform-
ants expressing a new P.I1 protein. The ability to recover
transformants was not affected by the P.11 protein expres-
sion state of the recipient cells. In the experiment shown in
Fig. 2, the FA759 recipient expressed a P.11 protein. In other
experiments, recipients not expressing P.II proteins were
equally capable of being transformed for FA1090 P.11 genes.
The transformation frequency varied from 10-2 to 10-3
transformants per recipient cell. A more extensive purifica-
tion of donor DNA by organic extraction by the procedure of
Marmur (15) did not alter the transformation frequency of
P.JI genes. Transformants that were characterized further
were always from experiments in which the DNA concen-
tration was not saturating, to minimize the possibility of the
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Transformants that expressed individually each of the six
different antibody-binding P.II proteins characteristic of the
donor were recovered and screened for their ability to turn
on the synthesis of the other P.II proteins of the donor by
using the other antibodies to probe the transformants by a
colony blot RIA. Acquisition of the ability to make one P.II
protein of the donor strain did not confer the ability to make
the other P.II proteins of the donor strain, suggesting that
these P.II proteins are the products of different genes. These
results are consistent with information from an amino acid
sequence analysis of P.II proteins which suggests that the
proteins synthesized by a single strain must be products of
similar but distinct structural genes (21).
The single reported linkage group on the gonococcal
chromosome is a cluster of antibiotic resistance loci and
genes affecting outer membrane protein and lipopolysaccha-
ride structure (5). We examined cotransformation frequen-
cies of genes coding for P.11 proteins with markers in the
linkage group (rif, str, spc) in an attempt to map P.II genes.
Donors were mutants of FA1090 resistant to rifampicin,
streptomycin, or spectinomycin, and the recipient was strain
FA19 (antibiotic sensitive). For each marker, several hun-
dred antibiotic-resistant transformants were probed by a
colony blot RIA with MAb H.4a (anti-P.IIb and anti-P.IId)
and H.138 (anti-P.IIa). None of the transformants bound
either of the antibodies, indicating that loci affecting the P.11
proteins and resistance to these antibiotics were not linked.
Heritability of the P.11 protein expression state. P.II pro-
teins are subject to phase variation, in which expression is
reversibly switched on and off (11, 29). To determine if the
P.II protein expression state of the donor affected the ability
to transform P.II genes, we prepared DNA from colony








FIG. 2. Transformation of an FA1090 P.IIb structural gene:
identification of the gene product by SDS-PAGE and Western
blotting. (A) SDS-PAGE of outer membranes of donor strain
FA1090 expressing P.IIb (lanes 1090), a colony blot RIA-positive
FA759 transformant (lanes 759 Tf), and the untransformed recipient
strain (lanes 759). To demonstrate the characteristic heat modifica-
tion of the proteins, we solubilized outer membranes in each pair of
lanes at 37°C for 60 min (left) or 100°C for 5 min (right) prior to
electrophoresis. P.JI proteins migrated with a higher apparent
molecular weight when samples were prepared at 100°C. (B) Auto-
radiograph of a Western blot of the gel in panel A probed with MAb







FIG. 3. Colony blot RIA of transformation mixtures probed with
donor P.11 protein-specific MAb. Donor DNA prepared from
FA1090 expressing P.IIa was used to transform FA19 recipient
cells. The transformation mixture (approximately 10i CFU per agar
plate) was probed with the indicated FA1090 P.11 protein-specific
MAb.
proteins and used it to transform FA19 recipient cells that
did not express a P.11 protein. The transformation mixture
was probed with the donor-specific MAb by a colony blot
RIA. In each case, transformants were recovered that ex-
pressed the P.11 species that were expressed in the FA1090
variants used to prepare the DNA, but no transformants
were found that expressed the P.II proteins that were not
expressed in the donor variants. If the donor expressed only
P.IIa, transformants expressing P.IIa were recovered, but
no transformants expressing other FA1090 P.11 proteins
were found (Fig. 3 and Table 1). If the donor expressed
P.IIa, P.IIb, and P.IIf, transformants were isolated that
expressed each of the three donor proteins. However, each
individual transformant in the mixture expressed only one of
the donor-type proteins, suggesting that the genes coding for
these expressed P.II proteins were not linked on the gono-
coccal chromosome. The frequency of transformation of
donor P.II genes was not affected by differences in the P.II
protein expression state of the recipient, as competent cells
of FA19 were transformed at similar frequencies whether or
not they expressed a P.II protein.
These results indicated that the state of expression of a
donor P.II gene was important in determining the outcome of
a transformation. Silent P.II genes may have been trans-
formed in an unexpressed state, or they may not have been
introduced into FA19 at all. It is also possible that unex-
pressed P.11 genes may not be structurally intact. Conver-
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TABLE 1. Effect of the donor P.11 protein expression state on
the recovery protein of P.11 protein transformants
Bindinga of FA19 transformants to
P.11 protein expression of donor MAb:
FA1090 colony variant
Anti P.IIa Anti P.IIb Anti P.IIf
P.IIa + - -
P.IIb - + -
P.IIf - - +
P.IIa P.IIb + +
P.IIa P.IIb P.IIf + + +
a +, Binding; -, no binding.
sion of a P.11 protein-negative expression state to a P.11
protein-positive expression state could involve intragenic
recombination of silent P.11 protein sequences, as has been
described for gonococcal pil sequences (23). Silent and
expressed P.II genes or sequences that flank the structural
genes differed in some way that was conserved through the
isolation and purification of transforming DNA and the
transformation itself. Analogous results have been obtained
in studies of Salmonella flagellar phase variation, a process
that is subject to recombinational regulation (24). The state
of expression of a flagellar gene is a heritable trait and can be
transferred into a recipient strain (14). Our data showing an
effect of the P.II protein expression state on transformation
are consistent with the observed structural differences be-
tween a gene coding for a P.11 protein and a cloned gene
equivalent from a variant that did not express a P.II protein.
Stern et al. showed by heteroduplex analysis that plasmids
containing these cloned genes differ at a single Si nuclease-
sensitive region (26).
Colony variants with altered regulation of P.11 protein
expression. In general, P.II protein expression is turned on
and off at a high frequency. One measure of this process is to
determine the size of the non-P.II-protein-bearing minority
population within a particular P.11 protein-expressing colony
variant. MAb H.138.2 (specific for P.IIa) and H.4a (specific
for P.IIb and P.IId) are bactericidal for colony variants
expressing P.IIa and P.IIb, respectively (1). Counting the
number of survivors in a bactericidal assay gives an assess-
ment of the size of the minority population. For most colony
variants, the percentage of survivors ranges from 0.1 to 1%
(1).
In the course of performing bactericidal assays on approx-
imately 100 different P.IIb-expressing colony variants of
FA1090, we observed that three independent variants were
reproducibly killed with a 1,000-fold greater efficiency than
usual. These variants contained a smaller non-P.IIb popula-
tion (approximately 1 in 106 CFU), which may have reflected
a decrease in the rate of loss of P.IIb expression. This
phenotype was designated P.IIb*. The P.IIb* phenotype was
relatively unstable. After nonselective daily passage for 3
weeks, 13 of 15 P.IIb-expressing colonies displayed a "nor-
mal" survival rate in a bactericidal assay. P.IIb* variants
could be maintained by single-colony passage from stock
cultures stored at -70°C. However, because of the instabil-
ity of the phenotype, they were passed no longer than 1
week. The phenotype rarely persisted through changes in the
P.11 protein expression state. We determined the switching
frequency of a "third-generation" P.IIb population by first
performing a bactericidal assay on P.IIb* with MAb H.4a.
SDS-PAGE of outer membranes prepared from the survi-
vors revealed that most did not express a P.I1 protein, a
result which was consistent with previous data (1). P.IIb-
negative clones were expanded and probed for reexpression
of P.IIb by a colony blot RIA with H.4a. A bactericidal assay
was repeated with the P.IIb-positive clones. Only 1 of 16
P.IIb variants had the P.IIb* phenotype. All of 50 P.IIa
variants that were similarly derived from P.II protein-
negative bactericidal survivors with MAb H.138.2 (P.IIb* >
P.11 protein negative -+ P.IIa) showed a normal survival rate
after exposure to a bactericidal P.IIa-specific MAb. We
could not cotransform the P.IIb* phenotype with the P.IIb
structural gene. These results suggest that there may be
factors affecting the regulation of expression of genes for
individual P.II proteins, although there is no direct evidence
for the existence of such factors.
This study provided genetic evidence for the existence of
multiple P.11 genes in the gonococcus. Additionally, genetic
transformation experiments suggested that expressed and
unexpressed forms of a P.II gene display fundamental dif-
ferences. We do not know if these differences are in the
structural gene itself or in flanking sequences that cotrans-
form with the structural gene. The data are compatible with
studies on the physical characterization of cloned P.II genes
demonstrating that structural differences accompany
changes in P.II protein expression (26, 27). It is tempting to
speculate that the differences may occur in a cis-acting
regulatory element similar to those described in other phase
variation systems, although we do not have direct evidence
for the existence of such an element. The existence of colony
varients that differed in the rate of switching off of P.II
protein expression (P.IIb*) suggested that additional regula-
tory mechanisms may exist.
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